戻る Agenda
EUnetHTA Town Hall: Impact of Health Technology Assessment when Evidence (Regulatory vs Relative), Costs and Patient Expectations are Challenging to Combine
Session Chair(s)
Niklas Hedberg, MPHARM
HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
EUnetHTA Town Hall: Impact of Health Technology Assessment when Evidence (Regulatory vs Relative), Costs and Patient Expectations are Challenging to Combine
Speaker(s)
Regulator Perspective
Marie Gardmark
Swedish Medicines Agency (MPA), Sweden
Head of Licensing
Payer Perspective
Robert Sauermann, DrMed
Austrian Federation of Social Insurances, Austria
Deputy Head of Department of Pharmaceutical Affairs
Industry Perspective
Adam Parnaby
Bristol Myers Squibb, Belgium
Senior Director, Market Access Policy
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board